AMEOS opens new medical campus in Germany

AMEOS Gruppe, Germany’s fourth largest hospital group by revenue, has opened a medical campus in Halberstadt, Saxony-Anhalt, to provide the clinical stage of medical degrees for 40 doctors a years, as part of a degree program which AMEOS has been running for the past three years in partnership with a Croatian university.

German hospital sector turmoil may ultimately benefit for-profits

For-profit hospital groups in Germany are not immune to the cost pressures which are causing many public hospitals to become insolvent. But the CEO of Germany’s fourth largest group, Ameos, tells us the restructuring of Germany’s hospital sector is necessary, and that for-profit groups may ultimately benefit by gaining greater market share.

EU’s AI Act gets the greenlight from the European Commission

Despite opposition, the AI Act seems to be ploughing ahead right on schedule. This week, two key groups of lawmakers - the European Commission's civil liberties (LIBE) and internal market (IMCO) committees - gave their overwhelming support for the new law, which should come into force this summer.

EU states approve AI Act

In December, European policymakers gathered in Brussels to hash out the first framework for AI regulation. Despite threats to derail it, all 27 EU member states have now given it a collective thumbs up - but concerns around overregulation, bureaucracy, and the stifling of innovation remain. 

HR Round Up

January comes to an end, rounding off what has been a busy period in personnel changes. We review some of the senior appointments that kicked off the new year including at UK care home operator Cornerstone, property advisor Christie & Co, and healthcare conglomerate Fresenius.

Vamed and Median could merge to create rehab giant

Two of the largest rehab groups in Germany could be merged in what looks set to be one of 2024's biggest European health care services deals. Dutch PE firm Waterland Private Equity, which has owned Median Kliniken since 2014, is reportedly the front runner in the sale of Fresenius Vamed's rehab facilities.

New entrants could disrupt “tough” fertility market

The cost-of-living crisis is having a huge impact on fertility patients, making the sector ripe for disruption. A fertility expert tells HBI cunning new entrants will be the winners while established PE could well be the losers.

Find Us